CLINICAL, IMAGING FEATURES AND MANAGEMENTS OF UTERINE SARCOMA IN NATIONAL HOSPITAL OF OBSTETRICS AND GYNECOLOGY

Minh Hoàng Nguyễn , Thị Anh Đào Lê, Chiến Thắng Cù

Main Article Content

Abstract

Objective: Our study aims to describe some clinical and imaging characteristics and managements of uterine sarcoma. Methods: A retrospective cross-sectional descriptive study was conducted on 35 uterine sarcoma patients diagnosed and treated at the National Hospital of Obstetrics and Gynecology from January 2019 to December 2022. Results: The average age of patients was 51,3 ± 13,7 years-old. 51,4% of patients was menopaused. The most common symtom in uterine leiomyosarcoma was pelvic pain (73,6%), while in endometrial stromal sarcoma and adenosarcoma was post-menopaused vaginal bleeding (75%). In imaging diagnostics, most of them had one tumor with the characteristic of enhanced vascularity (58,8% of uterine leiomyosarcoma and 85% of endometrial stromal sarcoma and adenosarcoma). 15/35 patients were diagnosed correctly as uterine sarcoma before operation, maily due to pre-operated endometrial biopsy. The most common histopathological types were uterine leiomyosarcoma (54,2%) and endometrial stromal sarcoma (42,8%). The predominent initial management was complete hystorectomy (77,3%). Bilateral ovarian resection was applied coincidentally to 68,6 % of them. Of 11/35 patients dissected the pelvic lymph node, 27,3% was positive. Conclusion: Uterine sarcoma was commonly seen in pre-menopause and menopause. Uterine leiomyosarcoma and endometrial stromal sarcoma – adenosarcoma were the most common histopathological type, and they include different clinical and imaging features. The disease was mainly diagnosed after operation. Complete hysterectomy was the predominant mangagement.

Article Details

References

1. Brooks SE, Zhan M, Cote T, Baquet CR. Surveillance, Epidemiology, and End Results analysis of 2677 cases of uterine sarcoma 1989–1999. Gynecol Oncol. 2004;93(1):204-208.
2. Nguyễn QT. Một số nhận xét về ung thư tử cung tại bệnh viện Phụ sản Trung ương năm 2007-2008.2008.
3. Giuntoli RL, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003;89(3):460-469.
4. Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol. 2012;51(6):694-705. doi:10.3109/0284186X.2012.689111
5. Phạm Văn Bình. Nhận xét một số đặc điểm lâm sàng, cận lâm sàng bệnh nhân sarcom tử cung tại bệnh viện K.Tháng 2020:157-164.
6. Vrzic-Petronijevic S, Likic-Ladjevic I, Petronijevic M, Argirovic R, Ladjevic N. Diagnosis and surgical therapy of uterine sarcoma. Acta Chir Iugosl. 2006;53(3):67-72.
7. Chen I, Firth B, Hopkins L, Bougie O, Xie R hua, Singh S. Clinical Characteristics Differentiating Uterine Sarcoma and Fibroids. JSLS. 2018;22(1):e2017.00066.
8. Naaman Y, Shveiky D, Ben-Shachar I, Shushan A, Mejia-Gomez J, Benshushan A. Uterine sarcoma: prognostic factors and treatment evaluation. Isr Med Assoc J IMAJ. 2011;13(2):76-79.
9. Terek MC, Akman L, Hursitoglu BS, et al. The retrospective analysis of patients with uterine sarcomas: A single-center experience. J Cancer Res Ther. 2016;12(1):309-313.